ArticleFrontiers in public health2025
Impact of COVID-19 on national health screening participation and chronic disease detection: evidence from South Korea's NHIS database.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic disrupted preventive healthcare services worldwide, raising concerns about missed diagnoses of chronic diseases. South Korea's national health screening program experienced a substantial decline in participation during 2020. This study investigated how changes in screening rates influenced chronic disease detection and what these shifts reveal about the resilience of the national health system. Methods: Using the Korea Disease Control and Prevention Agency-National Health Insurance Service (K-COV-N) database, we analyzed trends in national health screening participation (2010-2020) and new diagnoses of hypertension, diabetes mellitus, and dyslipidemia before (2019) and during (2020) the COVID-19 pandemic. Analyses were stratified by sex and 10-year age groups to partially control for confounding factors. Relative risks (RRs) and 95% confidence intervals (CIs) for newly diagnosed chronic diseases were calculated for individuals who underwent health checkups and those who did not. Results: Health screening participation dropped from 75.4% in 2019 to 68.7% in 2020. Despite this decrease, new diagnoses of chronic diseases increased by approximately 550,000 cases in 2020 compared with 2019. Hypertension, diabetes, and dyslipidemia all showed higher relative risks among individuals who underwent screenings than among those who did not. Cardiovascular and cerebrovascular diseases declined, while heart failure increased slightly. Conclusion: The decline in preventive health screening did not correspond to a decline in chronic disease detection, suggesting a behavioral and systemic shift toward alternative diagnostic pathways. These findings underscore a resilient yet uneven health system, revealing both adaptive strengths and structural vulnerabilities that maintain continuity of essential services during public health crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.